Por favor, use este identificador para citar o enlazar este Item:http://hdl.handle.net/20.500.12105/16326
Título
Target product profile for a diagnostic test to confirm leprosy in individuals with clinical signs and symptoms
Autor(es)
Fecha de publicación
2023
Cita
World Health Organization. (2023). Target product profile for a diagnostic test to confirm leprosy in individuals with clinical signs and symptoms. World Health Organization
Idioma
Inglés
Tipo de documento
technical report
Resumen
Leprosy, is a chronic infectious disease caused by Mycobacterium leprae or, in some cases, by Mycobacterium lepromatosis. The bacteria is likely transmitted via tiny droplets (aerosols) from the nose and mouth during close and frequent contact with untreated cases. In some circumstances, skin-to-skin contact has also been implicated. Close and frequent contact increase the risk of contacts developing leprosy. Stigmatization and discrimination impede the life of an individual suffering from leprosy; overcoming them is an essential part of leprosy control. As with other neglected tropical diseases (NTDs), the occurrence of leprosy is often related to socioeconomic determinants of health. Despite the available treatment, more than 200 000 new leprosy patients were diagnosed globally in 2019, Early case detection is important to help contain the spread of infection and prevent disabilities.
Tabla de contenidos
1. Epidemiology. 2. Public health response. 3. Available diagnostic tools. 4. WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases. 5. WHO Technical Advisory Group on Leprosy. 6. Purpose of the Target product profile (TPP). 7. Audiences engaged and external consultations to develop the diagnostic TPP.
Palabras clave
Leprosy | Diagnostic test | Clinical signs | Clinical symptoms | Tropical diseases | Mycobacterium leprae
Versión en línea
Aparece en las colecciones